Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
63 hedge funds and large institutions have $144M invested in Five Prime Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 8 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
2% more funds holding
Funds holding: 62 → 63 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $177M → $144M (-$33.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.21M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.16M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.06M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$2.64M |
| 5 |
Millennium Management
New York
|
+$1.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$6.82M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.09M |
| 3 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$622K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$550K |
| 5 |
Goldman Sachs
New York
|
-$409K |
FPRX Hedge Fund Activity: Q3 2014 in Review
63 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2014, worth a combined $144M — down 19% from $177M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FPRX positions and 8 closed out — a net gain of 1 holder — while 20 added to existing stakes and 17 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $5.21M. The largest seller was Franklin Resources, exiting entirely with an estimated $6.82M sold.
- 63 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2014, up from 62 in Q2 2014.
- Funds reported $144M of Five Prime Therapeutics, Inc. stock for Q3 2014, down 19% quarter-over-quarter.
- 9 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2014 and 8 closed out, a net change of +1 holder.
- The largest Five Prime Therapeutics, Inc. buyer in Q3 2014 was Adage Capital Partners, an estimated $5.21M added.
- The largest Five Prime Therapeutics, Inc. seller in Q3 2014 was Franklin Resources, an estimated $6.82M sold.
Based on aggregated 13F filings for Q3 2014.